Page last updated: 2024-11-02

pioglitazone and Craniofacial Pain

pioglitazone has been researched along with Craniofacial Pain in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
" 2) Systemic administration of a PPARγ agonist, pioglitazone (PIO), attenuates whisker pad mechanical allodynia at doses of 300 mg/kg i."3.85PPARγ Agonists Attenuate Trigeminal Neuropathic Pain. ( Danaher, RJ; Lyons, DN; Miller, CS; Westlund, KN; Zhang, L, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lyons, DN2
Zhang, L2
Danaher, RJ2
Miller, CS2
Westlund, KN2
Pandya, JD1
Ma, F1
Sullivan, PG1
Sirbu, C1

Other Studies

2 other studies available for pioglitazone and Craniofacial Pain

ArticleYear
PPARγ Agonists Attenuate Trigeminal Neuropathic Pain.
    The Clinical journal of pain, 2017, Volume: 33, Issue:12

    Topics: Analgesics, Non-Narcotic; Anilides; Animals; Disease Models, Animal; Facial Pain; Hyperalgesia; Male

2017
Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury.
    The Clinical journal of pain, 2018, Volume: 34, Issue:2

    Topics: Analgesics; Animals; Anti-Anxiety Agents; Anxiety; Brain; Chronic Pain; Cognition; Cycloserine; Dise

2018